About this trial
The goal of this observational cross-sectional study is to investigate whether the severity of facial dysfunction is associated with psychological distress in patients with unilateral facial palsy.
The main questions it aims to answer are:
* Is there a significant relationship between the degree of facial muscle dysfunction (as measured by Sunnybrook Facial Grading Scale and EMG parameters) and levels of anxiety and depression (as measured by HADS)? * Does reduced facial function correlate with lower self-esteem levels (as measured by the Arabic version of the Single-Item Self-Esteem Scale)?
Researcher will assess and analyze the correlation between facial motor impairment and psychological outcomes to determine whether greater functional impairment is associated with increased psychological distress.
Participants will:
* Undergo clinical assessment using the Sunnybrook Facial Grading Scale to evaluate facial nerve function * Receive electrophysiological evaluation using surface electromyography (sEMG) to measure muscle activity * Complete standardized questionnaires including the Hospital Anxiety and Depression Scale (HADS) and the Arabic Single-Item Self-Esteem Scale (A-SISE)
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with unilateral idiopathic Bell's palsy confirmed by nerve conduction studies (NCS) will be included.
The age of patients ranged from 25 to 50 years.
The duration of Bell's palsy ranged from three months to two years.
Patients with a body mass index (BMI) less than 30 kg/m² will be included.
Disqualifiers
History of recurrent facial palsy or bilateral facial nerve involvement.
Presence of other neurological disorders unrelated to facial palsy affecting the face (e.g., stroke, multiple sclerosis).
A current diagnosis of psychiatric illness prior to the onset of facial palsy.
Cognitive impairment preventing valid completion of assessments.
Trial population
Eighty-five patients of both sexes with unilateral idiopathic Bell's palsy will be participate in this study. The patients diagnosis as having Bell's palsy based on careful clinical examination by a neurologist. The diagnosis will be confirmed by nerve conduction studies. Patients will be recruited from the outpatient clinic of the Faculty of Physical Therapy, Hours University.
Trial design
Other
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Multidimensional association between facial dysfunction and psychological outcomes
The primary outcome is to evaluate the association between facial dysfunction and psychological status using both clinical and electrophysiological measures. Facial motor function will be assessed using the Sunnybrook Facial Grading Scale (SFGS), while muscle activity will be quantified using surface electromyography (sEMG) (RMS amplitude). Psychological outcomes will be assessed using the Hospital Anxiety and Depression Scale (HADS) and the Arabic Single-Item Self-Esteem Scale (A-SISE). The analysis will examine the correlations between all variables, including: SFGS scores and HADS (anxiety and depression) SFGS scores and A-SISE sEMG (RMS) values and HADS scores sEMG (RMS) values and A-SISE
Secondary outcomes
Agreement between clinical and electrophysiological measures of facial function
To assess the relationship between SFGS scores and sEMG RMS values in selected facial muscles, reflecting the agreement between clinical grading and objective neuromuscular activity.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: